For example, CCL27 has previously been implicated in atopic dermatitis due to its ability to recruit CCR10 expressing CD4+ and CD8+ T cells; moreover, administration of an anti-CCL27 neutralizing antibody reduced dermal inflammation along with T and mast cell accumulation, T cell proliferation and the presence of inflammatory cytokines (15). This evidence concerns the gene CD4 and atopic eczema.